Spinal intervention involves the treatment of all maladies that
afflict the spine. The aim of spinal intervention is pain management,
wherein the focus is solely on the spine. The spine consists of 33
bones, which include 12 thoracic vertebrae, seven cervical vertebrae,
five sacral vertebrae, five lumbar vertebrae, and four coccygeal
vertebrae. The pedicle, which is a stub of a bone that connects the
lamina to the vertebral body to form an arch, is crucial in spinal
intervention, as it offers a safe and secured tunnel. Through this
tunnel, the interventionist examining the spine can get safe access to
the vertebral body for vertebroplasty, biopsy, and kyphoplasty. The
pedicles located in the cervical area are small and they have poor
access to the vertebral body. The size of the pedicles gradually
increases from the upper thoracic spine i.e. T4 to the lower lumbar
spine i.e. L5. Progressive angulation occurs toward the cervical area
from T4. Therefore, both pedicle size and angulation are equally
important while planning a transpedicular procedure during intervention.
Spinal decompression is performed to create sufficient space for the
nerves in the spinal canal, thereby diminishing the pain caused by
neural impingement. Spinal fusion is performed to stop movement at one
or more vertebral segments so as to relieve the pain and correct the
spinal instability. The aim of spinal fusion is to unwind the spinal
nerves that cause pain. This helps restore an appropriate gap between
the vertebrae that surround the diseased disc, eliminating the pain
caused during movement of the affected part.
Increase in the incidence of complications associated with the spine is one of the factors expected to increase health care costs worldwide. Other major factors are rise in the incidence of neurological diseases and neck deformities caused by obesity and injuries and increase in the incidence of degenerative disc disease, spondylolisthesis, prolapsed intervertebral circle, herniated disc, and spinal stenosis. The global spinal intervention market is expected to expand significantly in the next few years, due to high investments by major players in R&D activities and availability of government funds for promoting advanced technologies. However, lack of skilled, highly qualified, and well-experienced medical practitioners; high costs of surgery; and lack of awareness among patients about diagnosis are expected to be restraining factors for the global spinal intervention market during the forecast period.
The global spinal intervention market can be segmented based on
surgery type, procedure type, technology, end-user, and region. Based on
surgery type, the market can be segmented into open surgery and
minimally invasive (MI) surgery. Due to occurrences of unsuccessful
spinal surgeries, speedy research in newly developed techniques has been
started to improve the outcome. Advancements in percutaneous techniques
used in interventional procedures have lowered the invasive nature of
the surgery. They have also avoided issues involved in open surgery such
as infection and scarring. Based on procedure type, the global spinal
intervention market can be classified into laminectomy, corpectomy,
facetectomy, discectomy, and foraminectomy. Facetectomy is a procedure
performed to remove the facet cartilage with the spine, which can
promote easy fusion of bones. Non-fulfilment of this procedure can leave
the facet articular cartilage inside, which may block the bone fusion
by permitting the movement and contact between two cartilaginous
surfaces in the particular part. Discectomy is a procedure allowing the
removal of the herniated disc from the spinal canal. Laminectomy is a
back surgery procedure performed to release the compressed spinal cord.
Corpectomy is a procedure that helps relieve the damage caused to the
vertebrae and the intervertebral discs. Foraminectomy is a spinal
surgery procedure that decompresses the spinal nerves strained by the
tissues, the disc material, or the bone that has narrowed the foraminal
canal. Based on technology type, the global spinal intervention market
can be classified into spinal fusion technology, spinal fixation
technology, spinal non-fusion technology, annulus repair, dynamic
stabilization, artificial disc replacement (or disc nucleus
replacement), and vertebral compression fracture treatment. Based on
end-user, the global spinal intervention market can be segregated into
hospitals, research centers, and others.
Geographically, the global spinal intervention market can be divided
into five major regions: North America, Asia Pacific, Europe, Latin
America, and Middle East & Africa. The market in North America is
expected to lead the global market during the forecast period, due to
increasing number of spinal surgeries in countries in the region.
Prominent players operating in the global spinal intervention market are Abbott Laboratories Ltd., Medtronic Inc, Zimmer Biomet Holdings Inc, Orthofix International N.V., Stryker Corporation, Globus Medical Inc, Boston Scientific Corporation, BioControl Medical Ltd., Synapse Biomedical Inc., and DePuy Synthes Inc.
Increase in the incidence of complications associated with the spine is one of the factors expected to increase health care costs worldwide. Other major factors are rise in the incidence of neurological diseases and neck deformities caused by obesity and injuries and increase in the incidence of degenerative disc disease, spondylolisthesis, prolapsed intervertebral circle, herniated disc, and spinal stenosis. The global spinal intervention market is expected to expand significantly in the next few years, due to high investments by major players in R&D activities and availability of government funds for promoting advanced technologies. However, lack of skilled, highly qualified, and well-experienced medical practitioners; high costs of surgery; and lack of awareness among patients about diagnosis are expected to be restraining factors for the global spinal intervention market during the forecast period.
Prominent players operating in the global spinal intervention market are Abbott Laboratories Ltd., Medtronic Inc, Zimmer Biomet Holdings Inc, Orthofix International N.V., Stryker Corporation, Globus Medical Inc, Boston Scientific Corporation, BioControl Medical Ltd., Synapse Biomedical Inc., and DePuy Synthes Inc.
No comments:
Post a Comment